{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:07:24Z","timestamp":1793869644070,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1450-6","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:04:52Z","timestamp":1522800292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["HLA alleles modulate EBV viral load in multiple sclerosis"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-0645","authenticated-orcid":false,"given":"Simone","family":"Agostini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca R.","family":"Guerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"D\u2019Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Agliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Hernis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Zanzottera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Barizzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio A.","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rovaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"1450_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502\u201317.","journal-title":"Lancet"},{"key":"1450_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2003.08.009","volume":"143","author":"GAMES; Transatlantic multiple sclerosis genetics cooperative","year":"2003","unstructured":"GAMES; Transatlantic multiple sclerosis genetics cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol. 2003;143:39\u201346.","journal-title":"J Neuroimmunol"},{"key":"1450_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(72)90962-2","volume":"1","author":"C Jersild","year":"1972","unstructured":"Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet. 1972;1:1240\u20131.","journal-title":"Lancet"},{"key":"1450_CR4","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1212\/WNL.0b013e318263c407","volume":"79","author":"D Nolan","year":"2012","unstructured":"Nolan D, Castley M, Tschochner M, James I, Qiu W, Sayer D, et al. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Neurology. 2012;79:538\u201346.","journal-title":"Neurology"},{"key":"1450_CR5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00415-003-0164-7","volume":"250","author":"R Zivadinov","year":"2003","unstructured":"Zivadinov R, Uxa L, Zacchi T, Nasuelli D, Ukmar M, Furlan C, et al. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis. J Neurol. 2003;250:1099\u2013106.","journal-title":"J Neurol"},{"key":"1450_CR6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/ng.3395","volume":"47","author":"L Moutsianas","year":"2015","unstructured":"Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifar DK, Ban M, et al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet. 2015;47:1107\u201313.","journal-title":"Nat Genet"},{"key":"1450_CR7","doi-asserted-by":"publisher","first-page":"e664","DOI":"10.1371\/journal.pone.0000664","volume":"2","author":"B Brynedal","year":"2007","unstructured":"Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J, et al. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE. 2007;2:e664.","journal-title":"PLoS ONE"},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61:288\u201399.","journal-title":"Ann Neurol"},{"key":"1450_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB. Epstein-Barr virus: 40\u00a0years on. Nat Rev Cancer. 2004;4:757\u201368.","journal-title":"Nat Rev Cancer"},{"key":"1450_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","volume":"69","author":"B Serafini","year":"2010","unstructured":"Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta C, et al. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol. 2010;69:677\u201393.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1450_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2249.2003.02114.x","volume":"132","author":"P Hollsberg","year":"2003","unstructured":"Hollsberg P, Hansen HJ, Haahr S. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol. 2003;132:137\u201343.","journal-title":"Clin Exp Immunol"},{"key":"1450_CR12","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.4049\/jimmunol.1103100","volume":"188","author":"S Jilek","year":"2012","unstructured":"Jilek S, Schluep M, Harari A, Canales M, Lysandropoulos A, Zekeridou A, et al. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis. J Immunol. 2012;188:4671\u201380.","journal-title":"J Immunol"},{"key":"1450_CR13","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1093\/brain\/awr197","volume":"134","author":"H Lassmann","year":"2011","unstructured":"Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM, NeuroproMiSe EBV Working Group. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain. 2011;134:2772\u201386.","journal-title":"Brain"},{"key":"1450_CR14","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med. 2007;204:2899\u2013912.","journal-title":"J Exp Med"},{"key":"1450_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/1352458507086425","volume":"14","author":"R Alvarez-Lafuente","year":"2008","unstructured":"Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Dominguez-Mozo MI, Bartolome M, Benito-Martin MS, et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler. 2008;14:595\u2013601.","journal-title":"Mult Scler"},{"key":"1450_CR16","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/brain\/awp200","volume":"132","author":"SN Willis","year":"2009","unstructured":"Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain. 2009;132:3318\u201328.","journal-title":"Brain"},{"key":"1450_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","volume":"74","author":"SA Sargsyan","year":"2010","unstructured":"Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology. 2010;74:1127\u201335.","journal-title":"Neurology"},{"key":"1450_CR18","doi-asserted-by":"publisher","first-page":"18083","DOI":"10.1038\/srep18083","volume":"5","author":"D Xiao","year":"2015","unstructured":"Xiao D, Ye X, Zhang N, Ou M, Guo C, Zhang B, et al. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis. Sci Rep. 2015;5:18083.","journal-title":"Sci Rep"},{"key":"1450_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","volume":"70","author":"PL Jager De","year":"2008","unstructured":"De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology. 2008;70:1113\u20138.","journal-title":"Neurology"},{"key":"1450_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/gene.2011.42","volume":"13","author":"E Sundqvist","year":"2012","unstructured":"Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, et al. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun. 2012;13:14\u201320.","journal-title":"Genes Immun"},{"key":"1450_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneuroim.2009.01.023","volume":"209","author":"R Zivadinov","year":"2009","unstructured":"Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A, et al. Gene-environment interactions between HLA B7\/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. J Neuroimmunol. 2009;209:123\u201330.","journal-title":"J Neuroimmunol"},{"key":"1450_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol"},{"key":"1450_CR23","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.bbi.2011.05.015","volume":"25","author":"C Agliardi","year":"2011","unstructured":"Agliardi C, Guerini FR, Saresella M, Caputo D, Leone MA, Zanzottera M, et al. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav Immun. 2011;25:1460\u20137.","journal-title":"Brain Behav Immun"},{"key":"1450_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/1352458515596599","volume":"21","author":"N Barizzone","year":"2015","unstructured":"Barizzone N, Zara I, Sorosina M, Lupoli S, Porcu E, Pitzalis M, et al. The burden of multiple sclerosis variants in continental Italians and Sardinians. Mult Scler J. 2015;21:1385\u201395.","journal-title":"Mult Scler J"},{"key":"1450_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/jmv.21764","volume":"82","author":"R Mancuso","year":"2010","unstructured":"Mancuso R, Hernis A, Cavarretta R, Caputo D, Calabrese E, Nemni R, et al. Detection of vital DNA sequence in the cerebrospinal fluid of patients with multiple sclerosis. J Med Virol. 2010;82:1051\u20137.","journal-title":"J Med Virol"},{"key":"1450_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","volume":"73","author":"RA Farrell","year":"2009","unstructured":"Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology. 2009;73:32\u20138.","journal-title":"Neurology"},{"key":"1450_CR27","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-10-3327","volume":"17","author":"S Hohaus","year":"2011","unstructured":"Hohaus S, Santnagelo R, Giachelia M, Massini G, Cuccaro A, Martini M, et al. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res. 2011;17:2885\u201392.","journal-title":"Clin Cancer Res"},{"key":"1450_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13365-011-0056-z","volume":"18","author":"N Ben Fredj","year":"2012","unstructured":"Ben Fredj N, Rotola A, Nefz F, Chebei S, Rizzo R, Caselli E, et al. Identification of human herpesviruses 1\u20138 in Tunisian multiple sclerosis patients and healthy blood donors. J Neurovirol. 2012;18:12\u20139.","journal-title":"J Neurovirol"},{"key":"1450_CR29","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1212\/WNL.0b013e31826c1baf","volume":"79","author":"RM Lucas","year":"2012","unstructured":"Lucas RM, Taylor BV. Epstein-Barr virus infection: a smoking gun for multiple sclerosis? Neurology. 2012;79:1310\u20131.","journal-title":"Neurology"},{"key":"1450_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/1352458508097920","volume":"15","author":"JW Lindsey","year":"2009","unstructured":"Lindsey JW, Hatfield LM, Crawford MP, Patel S. Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis. Mult Scler. 2009;15:153\u20138.","journal-title":"Mult Scler"},{"key":"1450_CR31","doi-asserted-by":"publisher","first-page":"e94497","DOI":"10.1371\/journal.pone.0094497","volume":"9","author":"CE Cocuzza","year":"2014","unstructured":"Cocuzza CE, Piazza F, Musumeci R, Oggioni D, Andreoni S, Gardinetti M, et al. Quantitative detection of Epstein-Barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. PLoS ONE. 2014;9:e94497.","journal-title":"PLoS ONE"},{"key":"1450_CR32","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1128\/JCM.41.12.5419-5428.2003","volume":"41","author":"S Maurmann","year":"2003","unstructured":"Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, et al. Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers. J Clin Microbiol. 2003;41:5419\u201328.","journal-title":"J Clin Microbiol"},{"key":"1450_CR33","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/cti.2016.87","volume":"6","author":"MP Pender","year":"2017","unstructured":"Pender MP, Csurhes PA, Burrows JM, Burrows SR. Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clin Transl Immunology. 2017;6:e126.","journal-title":"Clin Transl Immunology"},{"key":"1450_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"International Multiple Sclerosis Genetics C, Wellcome Trust Case Control C, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214\u20139.","journal-title":"Nature"},{"key":"1450_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/1352458508100037","volume":"15","author":"TR Nielsen","year":"2009","unstructured":"Nielsen TR, Rostgaard K, Askling J, Steffensen R, Oturai A, Jersild C, et al. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler. 2009;15:431\u20136.","journal-title":"Mult Scler"},{"key":"1450_CR36","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1177\/1352458508092353","volume":"14","author":"P Sundstrom","year":"2008","unstructured":"Sundstrom P, Nystrom L, Jidell E, Hallmans G. EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult Scler. 2008;14:1120\u20132.","journal-title":"Mult Scler"},{"key":"1450_CR37","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1073\/pnas.0915054107","volume":"107","author":"H Hjalgrim","year":"2010","unstructured":"Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA. 2010;107:6400\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1450_CR38","doi-asserted-by":"publisher","first-page":"e39986","DOI":"10.1371\/journal.pone.0039986","volume":"7","author":"X Huang","year":"2012","unstructured":"Huang X, Kushekhar K, Nolte I, Kooistra W, Visser L, Bouwman I, et al. HLA associations in classical Hodgkin lymphoma: EBV status matters. PLoS ONE. 2012;7:e39986.","journal-title":"PLoS ONE"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1450-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1450-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1450-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T20:47:58Z","timestamp":1553633278000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1450-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1450-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"17 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"80"}}